Chris Tian Form 3 Filing for Anbio Biotechnology

This is a Form 3 filing by Chris Tian, the Chief Business Officer (CBO) of Anbio Biotechnology (ticker: NNNN). The filing reports that as of March 18, 2026, Chris Tian owns no securities in the company. The filing was signed on April 8, 2026, and indicates that Chris Tian is an officer of the company (CBO) but not a director or 10% owner. The filing is required under Section 16(a) of the Securities Exchange Act of 1934, which mandates that officers, directors, and principal shareholders file statements of ownership. This initial statement of beneficial ownership of securities shows that the officer currently holds no equity position in the company.